Article Archive: Michael Waterhouse

Title Collection Author Date
Mylan's Win is Teva's Loss Stock Analyst Update Michael Waterhouse 10/04/17
Teva's CEO News Is Encouraging Stock Analyst Update Michael Waterhouse 09/11/17
FDA Further Complicates Endo's Outlook Stock Analyst Update Michael Waterhouse 06/09/17
Continued Progress at Cooper Stock Analyst Update Michael Waterhouse 06/02/17
Diminished Confidence on Perrigo Stock Analyst Update Michael Waterhouse 05/31/17
Our Top Picks in the Generic Drug Industry US Videos Michael Waterhouse 05/15/17
Market Overly Negative on Teva Stock Analyst Update Michael Waterhouse 05/11/17
Valeant: Business Shows Some Stability, But ... Stock Analyst Update Michael Waterhouse 05/09/17
Generic Drug Industry Headwinds Lead to Moat Downgrades Stock Strategist Industry Reports Michael Waterhouse 05/05/17
Akorn Takeover Talk Unsurprising Stock Analyst Update Michael Waterhouse 04/10/17
Is Momenta's Drubbing Overdone? Stock Analyst Update Michael Waterhouse 02/21/17
Teva Faces Uncertainty Stock Analyst Update Michael Waterhouse 02/13/17
Illumina Should Dominate in High-Throughput Sequencing Stock Analyst Update Michael Waterhouse 01/10/17
Teva's Weak Forecast Leads to Fair Value Estimate Cut Stock Analyst Update Michael Waterhouse 01/06/17
Teva's Generics CEO Departure Cause for Concern Stock Analyst Update Michael Waterhouse 12/06/16
Allergan Is Our Top Pick in Specialty Pharma US Videos Michael Waterhouse 10/26/16
Allergan Still Undervalued Stock Strategist Michael Waterhouse 08/29/16
Undervalued Opportunities in Specialty Pharma US Videos Michael Waterhouse 03/30/16
Akorn On Track Stock Strategist Michael Waterhouse 03/28/16
Valeant's Disappointing Outlook Raises Default Fears Commentary Michael Waterhouse 03/15/16
Allergan Looks Cheap as Pfizer Deal Approaches Stock Strategist Michael Waterhouse 02/26/16
Lowering Valeant's Fair Value Estimate Commentary Michael Waterhouse 10/30/15
Baxter's Headwinds Mostly Temporary Stock Strategist Michael Waterhouse 07/03/15
Actavis' Wide-Moat Transformation Offers Shareholder Rewards Stock Strategist Michael Waterhouse 03/23/15
A Wide-Moat Opportunity in Health Care US Videos Michael Waterhouse 03/11/15
Leader in Genomic Sequencing Illuminates the Way Stock Strategist Michael Waterhouse 01/14/15
2 Wide Moats in Health Care US Videos Michael Waterhouse 11/14/14
Allergan Defends Its Territory Against Increased Competition Stock Strategist Michael Waterhouse 10/14/13
Unique Characteristics in Dental and Veterinary Distributor Markets Support Wide Economic Moats Stock Strategist Industry Reports Michael Waterhouse 07/05/13
Patient Trends Improving, but Reimbursement Outlook Remains Bleak for Health Service Providers Stock Strategist Industry Reports Michael Waterhouse 10/17/12
FDA Adapts to an Expanding Generic Drug Industry Stock Strategist Industry Reports Michael Waterhouse 11/21/11
No Bargains for No-Moat Health Service Providers Stock Strategist Industry Reports Michael Waterhouse 09/12/11
Generic Manufacturers Find Their New Medicine Stock Strategist Industry Reports Michael Waterhouse 04/08/11
A Healthy Challenge for Hospitals Stock Strategist Industry Reports Michael Waterhouse 03/30/11
Our Predictions for the Generics Industry Land Grab Stock Strategist Industry Reports Michael Waterhouse 09/08/10